英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03696 英矽智能

已收盘 01-12 16:08:28

54.500

+7.500

+15.96%

最高57.600	最低48.100	成交量690.42万
今开48.100	昨收47.000	日振幅20.21%
总市值303.79亿	流通市值303.79亿	总股本5.57亿
成交额3.68亿	换手率1.24%	流通股本5.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"英矽智能","latestPrice":54.5,"timestamp":1768205308529,"preClose":47,"halted":0,"volume":6904218,"delay":0,"floatShares":557418500,"shares":557418500,"eps":-0.238,"marketStatus":"已收盘","change":7.5,"latestTime":"01-12 16:08:28","open":48.1,"high":57.6,"low":48.1,"amount":368410657,"amplitude":0.202128,"askPrice":54.5,"askSize":5500,"bidPrice":54.45,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.624,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":5,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":47,"openAndCloseTimeList":[[1768181400000,1768190400000],[1768194000000,1768204800000]],"volumeRatio":1.656695,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03696","defaultTab":"news","newsList":[{"id":"2602944565","title":"JPM全球医疗健康大会催化 AI医疗概念股午后拉升 讯飞医疗科技(02506)涨13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602944565","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602944565?lang=zh_cn&edition=full","pubTime":"2026-01-12 15:51","pubTimestamp":1768204281,"startTime":"0","endTime":"0","summary":"金吾财讯 | AI医疗概念股午后拉升，讯飞医疗科技 涨13.38%，医脉通涨12.56%，英硅智能涨12.34%，医渡科技涨11.34%，方舟健客涨10.43%，阿里健康涨9.71%，微创机器人-B涨5.62%，京东健康涨5.32%，晶泰控股涨3.11%，平安好医生涨2.04%，固生堂涨0.20%。当地时间1月12日，全球生物医药行业的“春晚”——第44届摩根大通全球医疗健康大会即将正式在美国召开，预计为期4天。此外，医疗器械占比约16%，另包括诊断技术、数字健康、医疗服务板块。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/YWM4OGFlZWVjMzgwOWEyMjFjMjcxMjc0NzUxMTA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/YWM4OGFlZWVjMzgwOWEyMjFjMjcxMjc0NzUxMTA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973040","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0265550946.USD","02273","LU1261432733.SGD","86618","IE00BJLML261.HKD","XBI","IE00B3S45H60.SGD","BK4516","LU0256863811.USD","XLV","02228","LU1244550221.USD","02192","LU1046422090.SGD","LU1244550494.USD","02506","00241","BK4585","BK1247","LU0868494708.USD","02252","02158","LU1280957306.USD","LU2417539215.USD","BK1100","LU0882574139.USD","LU2357305700.SGD","LU0345770993.USD","159891","03696","06086","159760","LU1235295612.USD","LU2237443895.HKD","LU2264538146.SGD","LU2430703251.USD","06618","LU0689472784.USD","LU1548497426.USD","LU0640476718.USD","LU1032466523.USD","BK1615","LU0787776722.HKD","LABU","LU0942090050.USD","SGXZ62798434.SGD","01833","LU1116320737.USD","LU0943347566.SGD","BK1589"],"gpt_icon":0},{"id":"2602564576","title":"港股异动 | 英硅智能(03696)早盘涨近15% 治疗炎症性肠病候选药物IIA期临床试验完成首例给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2602564576","media":"智通财经","labels":["productRelease"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602564576?lang=zh_cn&edition=full","pubTime":"2026-01-12 10:02","pubTimestamp":1768183366,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能早盘涨近15%，高见54港元，较招股价24.05港元已涨超124%。消息面上，英硅智能宣布，公司已在一项名为BETHESDA的IIa期临床试验中完成其创新PHD抑制剂ISM5411的首例受试者给药。值得注意的是，1月5日，英硅智能发布公告称，与施维雅达成多年期抗肿瘤药物研发合作。英硅智能将有资格获得最高3200万美元的首付款及近期研发里程碑付款。施维雅共同承担研发成本，并主导后续临床验证及商业化进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 英硅智能(03696)早盘涨近15% 治疗炎症性肠病候选药物IIA期临床试验完成首例给药","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03696"],"gpt_icon":0},{"id":"2602561753","title":"2026年开年，“AI＋制药”领域合作活跃！","url":"https://stock-news.laohu8.com/highlight/detail?id=2602561753","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602561753?lang=zh_cn&edition=full","pubTime":"2026-01-12 09:42","pubTimestamp":1768182163,"startTime":"0","endTime":"0","summary":"据悉，2026年开年，就已有多家药企通过大规模、战略性的合作，将AI制药公司的创新能力深度整合进了自身的研发体系。值得一提的是，除了此次与施维雅达成的合作，近年来，英硅智能已经达成了数十项以AI驱动的药物研发合作和管线对外授权。基于此，业内认为，2026 年将是 AI + 制药从 “技术验证” 到 “商业落地” 的拐点，合作规模与临床进展将提速，监管与资本环境将持续优化，First-in-Class/Best-in-Class 药物的全球上市也将加速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112095826a70f7e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112095826a70f7e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696","BK1191","BK1574","01477"],"gpt_icon":0},{"id":"2602566845","title":"英硅智能：于BETHESDA的IIA期临床试验中完成GARUTADUSTAT (ISM5411)首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2602566845","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602566845?lang=zh_cn&edition=full","pubTime":"2026-01-12 08:10","pubTimestamp":1768176655,"startTime":"0","endTime":"0","summary":"格隆汇1月12日丨英硅智能发布公告，公司已在一项名为BETHESDA的IIa期临床试验中完成其创新PHD抑制剂ISM5411的首例受试者给药。该创新候选药物由集团自有生成式AI平台Pharma.AI辅助开发，具有肠道限制性，用于炎症性肠病的治疗，其通用名Garutadustat近期获得美国通用名委员会正式批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112081103a4b82d4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112081103a4b82d4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696"],"gpt_icon":0},{"id":"1168058667","title":"一周港股牛熊榜 | 开年医药股狂欢，劲方医药周涨45%；晶泰控股、英矽智能周升25%；融创中国、鸿腾精密下挫11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168058667","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168058667?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:22","pubTimestamp":1767950551,"startTime":"0","endTime":"0","summary":"总结全周， $恒生指数$ 跌106点或0.41%， $恒生科技指数$ 跌49点或0.86%；本周市值百亿以上、日均成交千万以上表现最好五只股票是 $劲方医药-B$ 、 $量化派$ 、 $荣昌生物$  、$晶泰控股$  、$英矽智能$ ；表现最差的五只股票是 $云知声$ 、 $融创中国$、  $鸿腾精密$  、$汇聚科技$  、$环球新材国际$ 。重点关注创新药产业链，景气度预计将持续向上。新年第一个完整周，英矽智能升25.07%。本公司亦已取得联交所批准换股股份上市及买卖。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228","09678","01729","01918","02595","03696","09995","02685","06616","06088"],"gpt_icon":1},{"id":"2602434824","title":"资本市场正迎来上海AI硬核力量密集登陆","url":"https://stock-news.laohu8.com/highlight/detail?id=2602434824","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602434824?lang=zh_cn&edition=full","pubTime":"2026-01-09 10:22","pubTimestamp":1767925336,"startTime":"0","endTime":"0","summary":"岁末年初，资本市场正迎来上海AI硬核力量的密集登陆：壁仞科技成为“港股国产GPU第一股”，沐曦股份科创板上市首日涨幅近7倍，英硅智能成为港交所AI制药标杆，天数智芯、稀宇科技紧随其后登陆港交所，曦智科技、智元机器人加速冲刺Pre-IPO……AI“芯”势力集体崛起就在昨天，天数智芯在港交所挂牌上市，成为继壁仞科技、沐曦股份之后第三家叩开资本市场大门的上海AI芯片龙头。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109102343a7053431&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109102343a7053431&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06082","03696","BK1163","09903"],"gpt_icon":1},{"id":"2601990334","title":"英硅智能盘中涨近5%创新高 公司宣布推出DORA社区版","url":"https://stock-news.laohu8.com/highlight/detail?id=2601990334","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601990334?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:53","pubTimestamp":1767844419,"startTime":"0","endTime":"0","summary":"来源：新浪港股英硅智能（03696）盘中涨近5%，盘中高见42.66港元，创上市新高。截至发稿，股价上涨3.06%，现报41.74港元，成交额9557.25万港元。1月8日，英硅智能宣布，公司推出DORA社区版（DORA Community Edition）——一款面向科学研究与内容创作的免费且可自主部署版本的综合性AI引擎。DORA社区版由英硅智能发起、并在微软支持下推出，旨在让更多人能够使用最前沿的科研工具，推动全球科研协作，提升科学研究的透明度，加速生物技术及学术界的创新进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108115559a4aa4e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108115559a4aa4e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696"],"gpt_icon":0},{"id":"2601338614","title":"英硅智能(03696)获 Microsoft Azure 支持开源 DORA，以多智能体大模型重塑科学研究与内容创作","url":"https://stock-news.laohu8.com/highlight/detail?id=2601338614","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601338614?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:43","pubTimestamp":1767833021,"startTime":"0","endTime":"0","summary":"DORA 社区版由英硅智能发起、并在微软支持下推出，旨在让更多人能够使用最前沿的科研工具，推动全球科研协作，提升科学研究的透明度，加速生物技术及学术界的创新进程。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260108/20260108084501_39981.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260108/20260108084501_39981.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0795875169.SGD","IE0009G5SDU7.USD","LU2168564065.EUR","LU1582987324.SGD","LU1983260115.SGD","LU0265550946.USD","LU0788109477.HKD","LU0889566641.SGD","LU1721428933.USD","IE00BKPKM429.USD","LU0661504455.SGD","LU1868836591.USD","LU2054465674.USD","SGXZ51526630.SGD","LU2125909593.SGD","LU0912757837.SGD","LU0154236417.USD","LU0312595415.SGD","LU2210149790.SGD","LU1261432733.SGD","SG9999015341.SGD","SG9999015986.USD","LU0310800379.SGD","LU2404859741.USD","LU0640476718.USD","LU1585245621.USD","LU2265009873.SGD","LU0444971666.USD","LU1852331112.SGD","LU0894486033.HKD","LU2326559502.SGD","SG9999002232.USD","LU0061474705.USD","LU2083900584.USD","LU2028103732.USD","LU2106854487.HKD","LU0210533765.USD","LU0511384066.AUD","LU1069347547.HKD","LU1340139317.AUD","SGXZ81514606.USD","LU0061474960.USD","LU0171293334.USD","LU0225283273.USD","BK4527","LU0029864427.USD","LU0456855351.SGD","LU2361045086.USD","LU0011850046.USD","BK4587","BK4543","LU1084165304.USD","LU1803068623.USD","LU0107464264.USD","LU1267930813.SGD","BK4516","LU2087625088.SGD","LU1301847155.USD","LU1116320737.USD","LU0347712357.USD","LU2360108059.USD","SG9999014898.SGD","LU0289960550.SGD","LU1032955483.USD","LU1791710582.SGD","LU2244417387.USD","BK4612","LU2505996509.AUD","LU1267930490.SGD","LU0203202063.USD","LU0072461881.USD","LU0545039389.USD","SGXZ31699556.SGD","LU2237443895.HKD","LU2413666699.HKD","SG9999004303.SGD","LU1221951046.USD","LU2750360997.AUD","GB00B4LPDJ14.GBP","LU1697837992.HKD","LU0784383803.USD","IE00B19Z8W00.USD","LU1582986433.USD","LU2237443382.USD","LU0353189680.USD","LU1043141123.HKD","IE00BFSS8Q28.SGD","LU2023250843.SGD","LU0057025933.USD","LU0276348264.USD","LU1778281490.HKD","LU0323239441.USD","GB00B4QBRK32.GBP","LU2430703095.HKD","LU0289961442.SGD","LU2461242641.AUD","LU1670628061.USD","IE00BJJMRY28.SGD","LU0417517546.SGD","IE0004091025.USD","SG9999015358.SGD","LU1720051017.SGD","LU1035775433.USD","LU1244550577.SGD","LU0784384876.USD","LU0106261372.USD","LU1674673691.USD","LU0545562505.USD","LU2286300806.USD","LU2065170008.USD","LU0256863811.USD","LU2746668461.USD","LU0689472784.USD","LU1623119135.USD","IE00B775SV38.USD","LU0097036916.USD","IE0003U64NQ7.SGD","LU2756315318.SGD","LU2430703251.USD","LU2089284900.SGD","LU0211328371.USD","LU0095938881.EUR","LU0302445910.USD","IE00BKVL7J92.USD","LU0006306889.USD","LU0170899867.USD","LU0353189763.USD","IE0009356076.USD","BK4525","IE00BQXX3C00.GBP","BK4567","IE00BWXC8680.SGD","LU1066051498.USD","LU2433249047.HKD","LU2491050154.USD","LU0289941410.SGD","LU0494093205.USD","BK4535","LU0234572021.USD","LU1720051108.HKD","LU0323240290.USD","LU2552382132.HKD","LU1989773731.SGD","LU0198837287.USD","LU1814569148.SGD","LU2491050071.SGD","LU2404859667.USD","LU0109391861.USD","LU0861579265.USD","LU1032466523.USD","LU2191332357.HKD","LU0345774391.USD","LU1815336760.USD","LU1935042215.USD","LU0708994859.HKD","LU1935043536.SGD","LU0889565833.HKD","IE0004445239.USD","LU2357305700.SGD","LU2279689827.SGD","LU2347655156.SGD","LU1267930730.SGD","LU2063271972.USD","LU1548497426.USD","LU1989764748.USD","LU1037948541.HKD","LU2413666426.HKD","LU1316542783.SGD","SGXZ23171101.USD","IE00B1XK9C88.USD","LU0965509283.SGD","LU1571399168.USD","SG9999015952.SGD","IE00B5949003.HKD","SG9999018865.SGD","LU1069344957.HKD","LU1236620750.USD","IE00BHPRN162.USD","LU1989772840.SGD","LU2543165471.USD","SG9999014542.SGD","LU0472753341.HKD","LU1670627923.USD","LU2242649171.HKD","LU2430703178.SGD","BK4528","LU2211815571.USD","LU1804176565.USD","LU0345769128.USD","LU0882574139.USD","LU0127658192.USD","LU0823434740.USD","IE00B19Z9505.USD","LU0124676726.USD","LU2242650005.HKD","LU2213496289.HKD","SG9999002224.SGD","LU1823568750.SGD","LU0390134368.USD","LU0354030511.USD","LU1732800096.USD","LU2092627202.USD","LU2458330169.SGD","LU0642271901.SGD","LU1228905540.USD","LU0251132253.USD","BK4581","LU2168564495.EUR","LU2247934214.USD","LU0210536198.USD","LU2360032135.SGD","LU1119994496.HKD","LU2023250504.SGD","LU0162691827.USD","LU0426412945.USD","LU0175139822.USD","LU1674673428.USD","LU2111349929.HKD","LU0949170426.SGD","LU0792757196.USD","LU2362541273.HKD","IE00BZ1G4Q59.USD","LU0316494557.USD","LU2092937221.SGD","LU0965508806.USD","LU1066053197.SGD","LU0823421416.USD","LU2456880835.USD","LU1496350502.SGD","LU1334329650.SGD","LU0323591593.USD","IE00BK4W5L77.USD","IE00BKDWB100.SGD","LU0820561818.USD","LU1629891620.HKD","LU0267386448.USD","LU2506951958.HKD","LU0820561909.HKD","LU2089283258.USD","GB00BDT5M118.USD","LU1236620834.HKD","LU1670710661.SGD","LU1934455277.USD","IE00BYXW3230.USD","BK4534","LU0690374615.EUR","IE00B4JS1V06.HKD","LU2462157665.USD","BK4503","LU2471134952.CNY","LU2602419157.SGD","BK4097","LU2381873111.SGD","IE00B5TLWC47.USD","LU0757359954.USD","LU0215105999.USD","LU1642822529.SGD","LU1803068979.SGD","LU1935042488.USD","LU0683600562.USD","LU1003077747.HKD","IE0005OL40V9.USD","LU0957791311.USD","LU2065171402.SGD","BK4576","LU2764262908.HKD","LU0690374961.EUR","LU1188199696.SGD","LU0708995401.HKD","LU1551013425.SGD","LU2237438978.USD","LU2463028550.USD","LU2077746001.SGD","LU2362541513.USD","BK4592","LU0879622024.SGD","IE00BJTD4N35.SGD","LU1582987597.SGD","LU1064131342.USD","BK4566","LU0096364046.USD","LU1917777945.USD","IE00BMPRXR70.SGD","LU0689626769.HKD","LU2471134523.USD","LU0314104364.USD","LU1868837136.USD","IE0034235303.USD","LU1232071149.USD","LU2125154935.USD","IE00BLSP4452.SGD","LU2452424414.USD","LU2041044095.USD","IE00BBT3K403.USD","LU1551013342.USD","BK4548","LU1564329032.USD","03696","LU0466842654.USD","IE00B19Z8X17.USD","LU0724617625.USD","LU1791710400.SGD","LU2417539215.USD","IE00BMPRXN33.USD","LU0345768153.USD","LU0128525929.USD","IE0034235295.USD","IE00BYQQ9H92.USD","LU2125909247.SGD","LU0354030438.USD","SG9999018857.SGD","LU2168563687.JPY","LU1914381329.SGD","LU1670711123.USD","LU1988902786.USD","LU2592432038.USD","LU0553294199.USD","SG9999001077.SGD","BK4554","LU0726765562.USD","LU1868836757.USD","LU0345770993.USD","LU1868837300.USD","SG9999001424.SGD","LU2168564149.EUR","LU2764263203.CNY","LU2298321311.HKD","LU0719512351.SGD","LU1861127337.USD","IE00BK4W5M84.HKD","LU0265550359.USD","BK4538","LU0960925559.SGD","LU1267930573.SGD","LU0964807845.USD","LU0234570918.USD","LU1074936037.SGD","LU0957808578.USD","LU0077335932.USD","LU1046421795.USD","LU0072462426.USD","LU1935042991.SGD","LU2360106780.USD","IE00BJJMRX11.SGD","IE00BN8TJ469.HKD","IE00BJLML261.HKD","LU1059921491.USD","IE00B3SWFQ91.USD","LU2264538146.SGD","LU2275660780.HKD","LU1989764664.SGD","LU0985320562.USD","IE00BJTD4V19.USD","LU2756315664.SGD","LU1989772923.USD","BK4579","LU2097344357.USD","LU2168564222.USD","IE00BQXX3F31.USD","LU0672654240.SGD","LU0238689110.USD","LU0096362180.USD","LU1221951129.SGD","LU0823417737.USD","LU0109392836.USD","LU1732799900.SGD","SG9999014906.USD","LU0757359368.USD","IE0004086264.USD","IE00BLSP4239.USD","LU2095319765.USD","LU0211327993.USD","LU1934455863.HKD","LU2237443549.SGD","LU1691799644.USD","LU2236285917.USD","LU0158827781.USD","LU0187121727.USD","LU2237957902.USD","LU2720916845.USD","LU0994945656.USD","LU1923622614.USD","LU2347655073.USD","LU1035773651.USD","LU1564329461.SGD","LU2471134796.USD","LU1121112475.USD","LU0943347566.SGD","LU1116320901.HKD","LU1633808545.USD","BK4585","LU2403377893.USD","IE000ITXATA3.USD","LU0823417653.USD","LU1127390331.HKD","LU0345770308.USD","LU1066051225.USD","LU0965509010.AUD","SG9999017495.SGD","LU0444973449.USD","LU2210150020.SGD","LU1935043023.USD","IE0034235188.USD","LU1430594728.SGD","SG9999014559.SGD","LU2133065610.SGD","LU2860962120.EUR","LU1506573853.SGD","SG9999015945.SGD","LU1037948897.HKD","LU2505996681.GBP","LU1435385759.SGD","LU2552382058.USD","LU2896262040.SGD","IE000KEQY171.SGD","LU1366333091.USD","LU0082616367.USD","LU0426417589.USD","LU2237957811.SGD","LU1244550494.USD","LU0795875086.SGD","LU1366192091.USD","LU1066051811.HKD","LU0528227936.USD","LU2506952097.USD","BK4598","LU0342679015.USD","LU2097829019.USD","LU1145028129.USD","IE000W1ABFV2.USD","IE0001KFT4U8.USD","IE00BSNM7G36.USD","LU0823421333.USD","BK4532","BK4533","LU0053666078.USD","LU0081259029.USD","LU0256863902.USD","LU1043141396.HKD","LU2023251221.USD","IE00B1BXHZ80.USD","LU0784385840.USD","BK4577","LU0738911758.USD","LU0157215616.USD","LU2271345857.HKD","BK4504","LU0949170772.SGD","LU0048584097.USD","SG9999015978.USD","LU2458330243.SGD","LU0149725797.USD","LU1153585028.USD","IE00BMPRXQ63.HKD","LU2087621335.USD","LU0345768740.USD","LU0314106906.USD","LU0070217475.USD","LU1564329115.USD","LU0823434583.USD","LU1839511570.USD","LU0950375773.USD","LU0094547139.USD","LU2506951875.HKD","LU2065171311.SGD","LU2764263039.SGD","LU0345769631.USD","LU0784385170.HKD","LU2065169927.USD","IE00B3S45H60.SGD","LU2491049909.HKD","LU0308772762.SGD","LU1712237335.SGD","LU2746668974.SGD","LU0310799852.SGD","SGXZ99366536.SGD","IE00BN29S564.USD","LU1974910355.USD","LU1934455194.USD","IE00B775H168.HKD","LU0557290698.USD","LU2487616109.SGD","LU2362540622.SGD","LU1564329628.SGD","LU2108987350.USD","IE00BDRTCR15.USD","LU0965509101.SGD","LU0345774631.USD","SG9999014880.SGD","LU0820562030.AUD","LU0080751232.USD","LU1280957306.USD","LU0266013472.USD","SG9999014575.USD","IE00B4YYXB79.USD","LU0203201768.USD","LU1244550221.USD","LU1235294995.USD","IE000YTNTUN2.SGD","LU1323610961.USD","LU2237443465.HKD","LU2361044865.SGD","LU1815333072.USD","SG9999000418.SGD","BK4550","LU0894485498.HKD","LU1989763005.USD","LU2361044949.HKD","LU0787776722.HKD","LU0348723411.USD","LU1670710588.SGD","LU1235295455.SGD","LU2097344431.USD","IE00BFXG0V08.USD","LU1196500208.SGD","LU2125154778.USD","LU2148611432.USD","LU2237443978.SGD","LU0320765059.SGD","BK4588","IE00BDCRKT87.USD","LU2750360641.GBP","IE00B7KXQ091.USD","SG9999014567.USD","LU1181866309.USD","LU0868494617.USD","LU0069063385.USD","LU1429558221.USD","LU1582986359.USD","LU1228905037.USD","LU2237443622.USD","LU2250418816.HKD","LU0056508442.USD","LU1718418525.SGD","LU2471134879.HKD","LU0289739343.SGD","LU0476273544.USD","LU2023250330.USD","LU0079474960.USD","LU2506952170.USD","IE00BFSS7M15.SGD","LU0061475181.USD","LU2420271590.USD","LU2092937148.SGD","LU1670711040.USD","LU0158827948.USD","LU1868836914.USD","LU2552382215.SGD","IE0004445015.USD","LU0210528500.USD","SG9999014914.USD","LU1496350171.SGD","IE00BQXX3D17.EUR"],"gpt_icon":1},{"id":"1125933632","title":"英矽智能（3696）2025年12月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1125933632","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125933632?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:53","pubTimestamp":1767776002,"startTime":"0","endTime":"0","summary":"英矽智能于2026年1月7日公布截至2025年12月31日的月份证券变动月报表。报告显示，公司注册股本及已发行股本在当月未发生变动，整体股本架构维持稳定。\\n\\n根据公告，公司本月末法定注册股本维持在1,270,000,000股，面值为每股USD 0.0000005，对应注册股本总额约USD 635。同期已发行普通股数量维持在557,418,500股，未有新增发行、购回或库藏股变动。本次月报由公司主席、执行董事兼首席执行官Aleksandrs Zavoronkovs签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"gpt_icon":0},{"id":"2601898014","title":"接连两起合作，MNC为何重仓中国AI制药？","url":"https://stock-news.laohu8.com/highlight/detail?id=2601898014","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601898014?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:20","pubTimestamp":1767691200,"startTime":"0","endTime":"0","summary":"2026年第一周，全球AI制药产业迎来两笔瞩目合作：赛诺菲与华深智药旗下Earendil Labs再次携手，合作总价值达25.6亿美元，合作从特定药物授权升级为覆盖多个项目的平台级战略合作，Earendil将应用其AI发现平台为赛诺菲发现和优化新型双特异性抗体；施维雅与英硅智能签署8.88亿美元研发合作协议，聚焦肿瘤靶点。英硅智能与施维雅的合作则基于其AI驱动的药物研发平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106173823a6f9ceae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106173823a6f9ceae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","03696","BK1191","01477"],"gpt_icon":0},{"id":"2601986781","title":"英硅智能01月06日获主力加仓839.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601986781","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601986781?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:15","pubTimestamp":1767687327,"startTime":"0","endTime":"0","summary":"01月06日, 英硅智能股价涨2.03%，报收38.14元，成交金额1.3亿元，换手率0.62%，振幅5.08%，量比0.00。英硅智能今日主力资金净流入839.9万元，上一交易日主力净流入463.9万元。该股近5个交易日上涨56.34%，主力资金累计净流入1043.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1043.4万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161722a4a27571&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161722a4a27571&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696"],"gpt_icon":0},{"id":"2601886148","title":"港股异动 | 英硅智能(03696)尾盘涨超3% 与施维雅达成多年期抗肿瘤药物研发合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886148","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601886148?lang=zh_cn&edition=full","pubTime":"2026-01-06 15:11","pubTimestamp":1767683517,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能尾盘涨超3%，截至发稿，涨2.89%，报38.46港元，成交额1.11亿港元。消息面上，1月5日，英硅智能发布公告，集团已与一家由基金会管理的全球独立制药公司施维雅达成多年期研发合作。值得一提的是，2025年12月30日，英硅智能正式登陆香港联合交易所主板，被市场公认为港股“AI制药第一股”。这两项数据均刷新了年内非18A港股医疗健康IPO的最高认购纪录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 英硅智能(03696)尾盘涨超3% 与施维雅达成多年期抗肿瘤药物研发合作","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03696"],"gpt_icon":1},{"id":"2601085621","title":"英硅智能与施维雅达成总额8.88亿美元合作：2026生物医药首例BD交易，2025年BD交易总额超1300亿美元创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2601085621","media":"蓝鲸财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601085621?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:22","pubTimestamp":1767658968,"startTime":"0","endTime":"0","summary":"图片来源：视觉中国蓝鲸新闻1月5日讯近日，根据国家药监督官微信息显示，2025年我国已批准上市的创新药达76个，大幅超过2024年全年48个，创历史新高。此外，2025年我国创新药对外授权交易总金额超过1300亿美元，授权交易数量超过150笔，远超2024年全年519亿美元和94笔，同样创历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106083041a6f7c092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106083041a6f7c092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","01477","03696"],"gpt_icon":1},{"id":"2601886483","title":"2026年全球生物医药BD首单来了，8.88亿美元押注AI抗肿瘤药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886483","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601886483?lang=zh_cn&edition=full","pubTime":"2026-01-05 19:58","pubTimestamp":1767614289,"startTime":"0","endTime":"0","summary":"刚刚于2025年12月30日在港交所成功上市的AI制药企业英硅智能，宣布与全球独立制药公司施维雅达成一项总价值高达8.88亿美元的战略合作。这不仅是英硅智能登陆资本市场后的首笔重大商业合作，也被业界视为2026年全球生物医药领域首笔高价值BD交易，标志着AI驱动的新药研发正加速获得国际主流药企的认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105200319a49ee57c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105200319a49ee57c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696"],"gpt_icon":1},{"id":"2601800478","title":"“低垂果实已摘完”！英硅智能联手施维雅，能否破局新药研发难？","url":"https://stock-news.laohu8.com/highlight/detail?id=2601800478","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601800478?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:05","pubTimestamp":1767603920,"startTime":"0","endTime":"0","summary":"上市数日后，该公司宣布，与施维雅达成价值8.88亿美元的多年期抗肿瘤药物研发合作，剑指抗肿瘤领域“具有挑战性的靶点”。战略互补对于医药产业而言，此次交易受到关注的一大原因在于，英硅智能与施维雅聚焦于“具有挑战性的靶点”。任峰介绍，目前，英硅智能3项对外管线授权合作总金额已超过21亿美元。针对市场提出的质疑，任峰指出，一方面，英硅智能采用多元化的商业模式，包括药物研发合作、管线对外授权以及软件授权等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105171248a6f54e35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105171248a6f54e35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696","BK1574","BK1191","01477"],"gpt_icon":1},{"id":"2601072015","title":"A股IPO回暖，创投机构也赚翻了","url":"https://stock-news.laohu8.com/highlight/detail?id=2601072015","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601072015?lang=zh_cn&edition=full","pubTime":"2026-01-05 12:32","pubTimestamp":1767587571,"startTime":"0","endTime":"0","summary":"比如，AI驱动生物科技公司英硅智能此次IPO募集资金总额22.77亿港元，成为2025年以来募集资金最高的港股生物医药IPO。从2025年全年来看，中国企业IPO持续升温，扮演耐心陪跑角色的创投机构有望因此获得可观回报。其中被投企业IPO案例数为1002笔，同比上升37.8%。多元退出路径形成2025年，A股IPO正不断回暖。除了IPO市场的回暖，S交易、并购也正式由“备选项”上升为退出路径的“主战场”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105123932a6f44d63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105123932a6f44d63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06082","03696"],"gpt_icon":1},{"id":"2601077769","title":"开年首弹！一家biotech 62亿元 “联姻” 跨国巨头","url":"https://stock-news.laohu8.com/highlight/detail?id=2601077769","media":"生物药大时代","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601077769?lang=zh_cn&edition=full","pubTime":"2026-01-05 11:39","pubTimestamp":1767584379,"startTime":"0","endTime":"0","summary":"其中，包括与 Exelixis、美纳里尼等公司达成的3项管线授权，总金额最高可达 21亿美元；牵手赛诺菲、礼来及复星医药等头部药企，达成AI驱动的药物研发合作；与诺和诺德、勃林格殷格翰、辉瑞等跨国药企达成AI软件对外授权合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105131455a6f469e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105131455a6f469e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696"],"gpt_icon":1},{"id":"2601073827","title":"8.88亿美元“联姻”跨国巨头 港股“AI制药第一股”英硅智能(03696)打响2026生物医药BD第一枪","url":"https://stock-news.laohu8.com/highlight/detail?id=2601073827","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601073827?lang=zh_cn&edition=full","pubTime":"2026-01-05 08:47","pubTimestamp":1767574050,"startTime":"0","endTime":"0","summary":"成一项为期多年的研发合作，协议涉及总金额高达8.88亿美元。2025年12月30日，英硅智能正式登陆香港联合交易所主板，被市场公认为港股“AI 制药第一股”。从“科技狂欢”到“临床硬战”，AI制药的下半场才刚刚开始8.88亿美元的BD大单与港股IPO的开门红，无疑为英硅智能乃至整个AI制药赛道注入了一剂强心针。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"553701c0628857e3aa8ad30c26408e63","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1191","03696","150131","BK1574"],"gpt_icon":1},{"id":"1146782811","title":"英矽智能与施维雅达成8.88亿美元多年期合作，共同推进肿瘤学领域药物发现与开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1146782811","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146782811?lang=zh_cn&edition=full","pubTime":"2026-01-05 08:31","pubTimestamp":1767573077,"startTime":"0","endTime":"0","summary":"人工智能驱动的临床阶段生物技术公司英矽智能宣布，已与全球领先的独立制药集团施维雅达成一项战略性多年期合作。此次合作旨在利用英矽智能专有的人工智能平台，共同发现和开发针对多个肿瘤学靶点的新型候选药物。\n根据协议条款，英矽智能将获得一笔预付款，并有资格获得高达8.88亿美元的研发、监管和商业里程碑付款，以及未来产品净销售额的分级特许权使用费。该合作将结合英矽智能在人工智能驱动药物发现方面的前沿技术与施维雅在肿瘤治疗领域的深厚专业知识和全球开发能力。\n此次合作聚焦于肿瘤学这一关键疾病领域，双方将致力于加速创新疗法的开发，以满足未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"553701c0628857e3aa8ad30c26408e63","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"gpt_icon":0},{"id":"2601832078","title":"英硅智能(03696)与施维雅达成价值8.88亿美元的多年期抗肿瘤药物研发合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2601832078","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601832078?lang=zh_cn&edition=full","pubTime":"2026-01-05 08:06","pubTimestamp":1767571577,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能 公布，集团已与一家由基金会管理的全球独立制药公司施维雅达成多年期研发合作。该合作价值高达8.88亿美元，将充分利用集团自主研发的人工智能平台Pharma.AI，聚焦于抗肿瘤领域具有挑战性的靶点，识别并开发全新的治疗药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"553701c0628857e3aa8ad30c26408e63","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"英硅智能(03696)与施维雅达成价值8.88亿美元的多年期抗肿瘤药物研发合作","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03696"],"gpt_icon":1}],"profile":{"websiteUrl":"http://insilico.com","stockEarnings":[{"period":"1week","weight":0.2507},{"period":"1month","weight":0.9543},{"period":"ytd","weight":0.2655}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"我们成立于2014年,为一家信誉卓著、业务遍布全球的AI驱动生物科技公司。我们的临床阶段资产目前包括一项处于II期临床阶段的资产,在业界同业中处于相对较为先进的阶段。截至最后实际可行日期,我们已透过自主开发的生成式人工智能平台Pharma.AI产生逾20项临床或IND申报阶段的资产,其中三项资产已授权予国际制药及医疗保健公司,合约总价值超过20亿美元。我们采用项目制业务模式运营,主要收入来源为对外授权及合作安排,惟无法保证或明确预测未来收入产生情况。平均而言,我们的候选药物从靶点发现到临床前候选药物确认需时12至18个月,远短于传统方法(平均需时4.5年)。我们独特的双引擎业务模式结合了生成式AI平台与深厚的自主药物研发能力,实现了持续的强化学习,不断提升Pharma.AI的能力并推动科学创新。我们亦正将Pharma.AI的应用范围扩展至多个行业,如先进材料、农业、营养产品及兽医药物领域。","exchange":"SEHK","name":"英矽智能","nameEN":"INSILICO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英矽智能,03696,英矽智能股票,英矽智能股票老虎,英矽智能股票老虎国际,英矽智能行情,英矽智能股票行情,英矽智能股价,英矽智能股市,英矽智能股票价格,英矽智能股票交易,英矽智能股票购买,英矽智能股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}